Close Menu

Suit Over a Marker

A biotech company is suing a prostate cancer researcher for making false claims concerning a disease biomarker, reports Science Insider. According to the Pittsburgh Tribune-Review, Robert Getzenberg, then at University of Pittsburgh and now at Johns Hopkins University, he found a biomarker, EPCA-2, for human prostate cancer that he and the University of Pittsburgh patented it.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.

A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.

The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.

In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.